Melatonin as a Modulator of Apoptosis in B-Lymphoma Cells

Melatonin is considered a promising antitumor agent, promoting apoptosis in tumor cells and contrasting it in normal cells. The basis for this selectivity is presumed to be the ability of melatonin to stimulate reactive oxygen species (ROS) production in tumor cells. Here we investigate the effect of melatonin on three types of human lymphocytes: normal blood lymphocytes, BL41 Burkitt lymphoma, and the cognate Epstein[ndash]Barr virus (EBV)-converted E2r. We found that melatonin promotes ROS production in all these cells. Melatonin protects BL41 from apoptosis in the same manner as normal lymphocytes, whereas E2r are unaffected. These results show that ROS production is not limited to tumor lymphocytes nor it is involved in apoptosis promotion; that melatonin does not promote apoptosis in …

Related posts:

1. Melatonin reverses apoptosis through which menadione inhibits intestinal calcium absorption
2. Blocking of melatonin synthesis and MT(1) receptor impairs the activation of Jurkat T cells.
3. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-α toxicity involves membrane melatonin receptors
4. Melatonin and Doxorubicin synergistically induce cell apoptosis in human hepatoma cell lines.
5. Melanoma, Vitiligo, and Uveitis